Bridging the antigen-presentation gap for adoptive cell therapies.
作者信息
Hont Amy B, Cruz C Russell Y
机构信息
Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
出版信息
Mol Ther Oncol. 2024 Sep 26;32(4):200877. doi: 10.1016/j.omton.2024.200877. eCollection 2024 Dec 19.
Abstract
摘要
相似文献
1
Bridging the antigen-presentation gap for adoptive cell therapies.弥合过继性细胞疗法的抗原呈递差距。
Mol Ther Oncol. 2024 Sep 26;32(4):200877. doi: 10.1016/j.omton.2024.200877. eCollection 2024 Dec 19.
2
Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma.嵌合抗原受体 T 细胞疗法治疗多发性骨髓瘤前的桥接治疗。
Br J Haematol. 2024 Feb;204(2):449-454. doi: 10.1111/bjh.19227. Epub 2023 Nov 30.
3
Bridging the Gap: Early Transition and Hybrid Models of Care to Improve Access to Chimeric Antigen Receptor T Cell Therapy.缩小差距：早期过渡与混合护理模式以改善嵌合抗原受体T细胞疗法的可及性
Transplant Cell Ther. 2023 Jun;29(6):399-402. doi: 10.1016/j.jtct.2023.03.021. Epub 2023 Mar 27.
4
Anti-CD19 CAR T Cells That Secrete a Biparatopic Anti-CLEC12A Bridging Protein Have Potent Activity Against Highly Aggressive Acute Myeloid Leukemia and .抗 CD19 CAR T 细胞分泌双表位抗 CLEC12A 桥接蛋白对高度侵袭性急性髓系白血病具有强大活性 ， 。
Mol Cancer Ther. 2021 Oct;20(10):2071-2081. doi: 10.1158/1535-7163.MCT-20-1030. Epub 2021 Jul 12.
5
Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.在“免疫逃逸”蛋白的影响下的抗原呈递及其被干扰素-γ的调节：抗病毒 CD8 T 细胞治疗巨细胞病毒感染的免疫治疗学意义。
Med Microbiol Immunol. 2012 Nov;201(4):513-25. doi: 10.1007/s00430-012-0256-z. Epub 2012 Sep 9.
6
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma.在商业嵌合抗原受体 T 细胞疗法治疗复发或难治性侵袭性 B 细胞淋巴瘤之前桥接放射治疗。
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):178-188. doi: 10.1016/j.ijrobp.2020.05.014. Epub 2020 May 22.
7
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors.工程化 CAR-巨噬细胞作为实体瘤的过继免疫疗法。
Front Immunol. 2021 Nov 24;12:783305. doi: 10.3389/fimmu.2021.783305. eCollection 2021.
8
Radiation prior to chimeric antigen receptor T-cell therapy is an optimizing bridging strategy in relapsed/refractory aggressive B-cell lymphoma.嵌合抗原受体T细胞疗法之前进行放疗是复发/难治性侵袭性B细胞淋巴瘤的一种优化桥接策略。
Radiother Oncol. 2022 Dec;177:53-60. doi: 10.1016/j.radonc.2022.10.018. Epub 2022 Oct 26.
9
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.英国接受 CD19 CAR T 治疗的大 B 细胞淋巴瘤患者接受放疗桥接的结果和可行性。
Br J Haematol. 2024 Aug;205(2):483-494. doi: 10.1111/bjh.19453. Epub 2024 Apr 9.
10
Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms.病例报告：嵌合抗原受体 T 细胞治疗前桥接放疗诱导局部压迫症状的复发/难治性双表达弥漫性大 B 细胞淋巴瘤患者持续缓解。
Front Immunol. 2024 Sep 3;15:1441404. doi: 10.3389/fimmu.2024.1441404. eCollection 2024.
本文引用的文献
1
A general pHLA-CD80 scaffold fusion protein to promote efficient antigen-specific T cell-based immunotherapy.一种通用的pHLA-CD80支架融合蛋白，用于促进基于高效抗原特异性T细胞的免疫疗法。
Mol Ther Oncol. 2024 Jun 10;32(3):200827. doi: 10.1016/j.omton.2024.200827. eCollection 2024 Sep 19.
2
Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation.人工抗原呈递细胞拓扑结构决定 T 细胞激活。
ACS Nano. 2022 Sep 27;16(9):15072-15085. doi: 10.1021/acsnano.2c06211. Epub 2022 Aug 15.
3
The generation and application of antigen-specific T cell therapies for cancer and viral-associated disease.针对癌症和病毒相关疾病的抗原特异性 T 细胞疗法的产生和应用。
Mol Ther. 2022 Jun 1;30(6):2130-2152. doi: 10.1016/j.ymthe.2022.02.002. Epub 2022 Feb 9.
4
One-step artificial antigen presenting cell-based vaccines induce potent effector CD8 T cell responses.一步法人工抗原提呈细胞疫苗诱导强烈的效应性 CD8 T 细胞应答。
Sci Rep. 2019 Dec 12;9(1):18949. doi: 10.1038/s41598-019-55286-5.
5
The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies.基于T细胞的癌症免疫疗法中人工抗原呈递细胞的基础
J Immunol Res Ther. 2017;2(1):68-79. Epub 2017 Jun 26.
6
T cells for viral infections after allogeneic hematopoietic stem cell transplant.异基因造血干细胞移植后针对病毒感染的T细胞
Blood. 2016 Jun 30;127(26):3331-40. doi: 10.1182/blood-2016-01-628982. Epub 2016 May 20.
Zotero 插件